MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on July 11, 2006; DOI: 10.1124/mol.106.027672


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.106.027672v1
70/4/1369    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pollenz, R. S.
Right arrow Articles by Dougherty, E. J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pollenz, R. S.
Right arrow Articles by Dougherty, E. J


Received for publication June 7, 2006.
Revised July 8, 2006.
Accepted for publication July 11, 2006.

ROLE OF ENDOGENOUS XAP2 PROTEIN ON THE LOCALIZATION AND NUCLEOCYTOPLASMIC SHUTTLING OF THE ENDOGENOUS MOUSE Ahb-1 RECEPTOR IN THE PRESENCE AND ABSENCE OF LIGAND

Richard S. Pollenz 1*, Sarah E Wilson 1, Edward J Dougherty 1

1 University of South Florida

* Address correspondence to: E-mail: pollenz{at}chuma1.cas.usf.edu

Abstract

Studies using transient expression systems have implicated the hepatitis B virus X-associated protein (XAP2) in the control of aryl hydrocarbon receptor (AHR) stability and subcellular location. Studies were performed in Hepa-1 cells to evaluate these functions of XAP2 on the mouse Ahb-1 receptor under endogenous stoichiometry. The Ahb-1 receptor is cytoplasmic and it becomes predominantly nuclear after 30-60 minutes of ligand exposure with minimal degradation. During this time, XAP2 co-precipitates with the AHR suggesting that it does not impact the nuclear localization of the liganded receptor. Over-expression of XAP2 in Hepa-1 cells does not result in increased association with the endogenous Ahb-1 complex or influence the receptors cytoplasmic localization. Knock down of endogenous XAP2 by siRNA results in >95% reduction in the amount of XAP2 associated with the endogenous Ahb-1 receptor complex. Despite the reduction in XAP2, the unliganded Ahb-1 receptor complex remains cytoplasmic, although inhibition of nuclear export results in accumulation of the receptor in the nucleus. Truncation of the C-terminal 305 amino acids of the Ahb-1 receptor (AHR500) results in proteins that exhibit a predominantly nuclear localization and remain associated with the same level of endogenous XAP2 as full length AHRs. Collectively, these results support a model in which the majority of the unliganded Ahb-1 receptor complexes are associated with XAP2 and the association prevents dynamic nucleocytoplasmic shuttling in the unliganded state. Following ligand binding, XAP2 remains associated with the Ahb-1 receptor complex and does not impair nuclear translocation but may function to limit receptor "transformation."


Key words: Molecular dynamics, Immunocytochemistry, Ah receptor


This article has been cited by other articles:


Home page
Eur J EndocrinolHome page
A. C. Pesatori, A. Baccarelli, D. Consonni, A. Lania, P. Beck-Peccoz, P. A. Bertazzi, and A. Spada
Aryl hydrocarbon receptor-interacting protein and pituitary adenomas: a population-based study on subjects exposed to dioxin after the Seveso, Italy, accident
Eur. J. Endocrinol., December 1, 2008; 159(6): 699 - 703.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Soshilov and M. S. Denison
Role of the Per/Arnt/Sim Domains in Ligand-dependent Transformation of the Aryl Hydrocarbon Receptor
J. Biol. Chem., November 21, 2008; 283(47): 32995 - 33005.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. A. Leontiou, M. Gueorguiev, J. van der Spuy, R. Quinton, F. Lolli, S. Hassan, H. S. Chahal, S. C. Igreja, S. Jordan, J. Rowe, et al.
The Role of the Aryl Hydrocarbon Receptor-Interacting Protein Gene in Familial and Sporadic Pituitary Adenomas
J. Clin. Endocrinol. Metab., June 1, 2008; 93(6): 2390 - 2401.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
T. Suzuki and K. Nohara
Regulatory Factors Involved in Species-specific Modulation of Arylhydrocarbon Receptor (AhR)-dependent Gene Expression in Humans and Mice
J. Biochem., October 1, 2007; 142(4): 443 - 452.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
X. Chang, Y. Fan, S. Karyala, S. Schwemberger, C. R. Tomlinson, M. A. Sartor, and A. Puga
Ligand-Independent Regulation of Transforming Growth Factor {beta}1 Expression and Cell Cycle Progression by the Aryl Hydrocarbon Receptor
Mol. Cell. Biol., September 1, 2007; 27(17): 6127 - 6139.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. E. Eltom and Y. Dale
Response to Comments on "Calpain Mediates the Dioxin-Induced Activation and Down-Regulation of the Aryl Hydrocarbon Receptor"
Mol. Pharmacol., January 1, 2007; 71(1): 386 - 387.
[Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
B. D. Hollingshead, R. D. Patel, and G. H. Perdew
Endogenous Hepatic Expression of the Hepatitis B Virus X-Associated Protein 2 Is Adequate for Maximal Association with Aryl Hydrocarbon Receptor-90-kDa Heat Shock Protein Complexes
Mol. Pharmacol., December 1, 2006; 70(6): 2096 - 2107.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics